Ecolab Inc.

Ecolab Inc. (ECL) Market Cap

Ecolab Inc. has a market capitalization of $72.60B.

Price: $257.97

3.64 (1.43%)

Market Cap: 72.60B

NYSE · time unavailable

CEO: Christophe Beck

Sector: Basic Materials

Industry: Chemicals - Specialty

IPO Date: 1957-01-01

Website: https://www.ecolab.com

Ecolab Inc. (ECL) - Company Information

Market Cap: 72.60B|Sector: Basic Materials

Company Profile

Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences segments. The Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, metals and mining, power generation, pulp and paper, commercial laundry, petroleum, refining, and petrochemical industries. The Global Institutional & Specialty segment provides specialized cleaning and sanitizing products to the foodservice, hospitality, lodging, government and education, and retail industries. Its Global Healthcare & Life Sciences segment offers specialized cleaning and sanitizing products to the healthcare, personal care, and pharmaceutical industries, such as infection prevention and surgical solutions, and end-to-end cleaning and contamination control solutions under the Ecolab, Microtek, and Anios brand names. The company's Other segment offers pest elimination services to detect, eliminate, and prevent pests, such as rodents and insects in restaurants, food and beverage processors, educational and healthcare facilities, hotels, quick service restaurant and grocery operations, and other institutional and commercial customers. This segment also provides colloidal silica for binding and polishing applications in semiconductor, catalyst, and aerospace component manufacturing, as well as chemical industries; and products and services that manage wash process through custom designed programs, premium products, dispensing equipment, water and energy management, and reduction, as well as real time data management. It sells its products through field sales and corporate account personnel, distributors, and dealers. The company was founded in 1923 and is headquartered in Saint Paul, Minnesota.

Analyst Sentiment

88%
Strong Buy

From 27 Active Polls

1Y Forecast: $332.10

▲ +28.7% Potential Upside

Consensus Target Metrics

Low Bound

$312

Median

$333

High Bound

$345

Average

$332

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$332.10
▲ +28.74% Upside
Low Target
$312.00
21% Risk
Median Target
$332.50
29% Mid
High Target
$345.00
34% Max
Consensus
Buy
27 / 37 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)72,60275,01874,16277,63976,35971,84866,94572,41267,023
Enterprise Value ($M)81,18283,59782,94585,11483,40679,04373,97179,45674,755
Price to Earnings Ratio (P/E)34.5543.3532.8833.1836.4244.6335.3924.5834.13
Price/Earnings-to-Growth Ratio (PEG)44.179.554.08211.2177.145.48
Price to Sales Ratio (P/S)4.4118.4517.6718.6418.9719.4416.7118.1116.82
Price to Book Ratio (P/B)7.277.507.597.998.198.097.648.478.09
Price to Free Cash Flow Ratio (P/FCF)38.82770.2097.84146.57157.41546.37164.48131.59161.81
Enterprise Value to Sales (EV/Sales)20.5619.7720.4420.7221.3918.4719.8718.76
Enterprise Value to EBITDA (EV/EBITDA)24.72136.3391.81107.8885.3096.6187.1860.9782.56
Debt to Equity Ratio2.610.910.970.970.960.940.950.970.98

ECL Growth Runway Model

Standard long term linear growth fade

Multi-Stage Discounted Cash Flow Sandbox

Market Price$257.97
Intrinsic Value$122.50
Market Alignment
Overvalued by 52.5%relative to calculated intrinsic value
9.00%
Exp: 0%0%
i

Growth runway slowdown

This value provides a time window for the growth rate to decline beyond Stage 1 toward the terminal rate. Longer windows are most useful for companies with high growth starting conditions or strong competitive advantages. This option stretches out the growth rate slowdown across 5, 10, or 15-year steps. A high-growth starting condition (exceeding a 25% initial growth rate) automatically applies a curve decay to simulate realistic, rapid market saturation.
i

Terminal growth rate

With long-term inflation between 3-5%, revenue must grow by that baseline to maintain flat real-world market share. This value sets the permanent terminal growth rate to factor into the valuation beyond the growth slowdown runway toward maturity.

3-Stage Financial Runway Horizon

🧠 Perpetuity Horizon Engine (Stage 3: Post-2035)

Terminal FCF Base$3.31B
Perpetuity TV Value$62.24B
Discounted TV (PV)$26.29B
TV Weighting %57.8%
⚠️
Financial Model Disclaimer & Risk Disclosure: This interactive scenario simulator is an educational sandbox provided strictly for informational and analytical research purposes. Core historical financial statements and consensus estimates are sourced directly via Financial Modeling Prep (FMP). All downstream outputs are entirely deterministic, hypothetical projections generated by combining automated mathematical formulas (including linear interpolation and Gaussian bell-curve decay models) with user-selected variables and third-party financial data inputs. Users assume all liability for trading decisions executed based on these sandbox calculations.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 ECOLAB INC (ECL) — Investment Overview

🧩 Business Model Overview

Ecolab supplies mission-critical chemicals, equipment, and application services used to manage hygiene, cleaning, and water treatment across food processing, healthcare, hospitality, industrial manufacturing, and institutional end-markets. The model combines (1) formulation and delivery of specialty products, (2) on-site and technical support to optimize chemistry and dosing, and (3) equipment integration that enables consistent outcomes (clean-in-place, disinfection, wastewater and water treatment performance).

Customer value is realized through reduced downtime and waste, improved compliance with sanitation standards, and more efficient water/energy use. Stickiness emerges because these programs are operationally embedded—tied to plant SOPs, equipment, training, and ongoing performance verification—making vendor changes costly and disruptive.

💰 Revenue Streams & Monetisation Model

Revenue is generated through a mix of:

  • Consumable chemical sales (transactional, but recurring in practice due to ongoing usage).
  • Equipment and program components that support dosing, monitoring, or treatment processes (typically lumpy and lower in share than consumables).
  • Services and application support, including on-site technical assistance, process optimization, and maintenance/program management (more recurring, with repeatable service demand).

Margin drivers generally include: (1) portfolio mix toward higher value specialty chemistries and services, (2) pricing discipline and product differentiation, and (3) operational leverage from manufacturing efficiency and field service productivity. Working-capital management and logistics execution also influence cash conversion due to the distribution intensity of chemical supply chains.

🧠 Competitive Advantages & Market Positioning

Ecolab’s moat is primarily rooted in switching costs and process/operational integration, reinforced by scale and technical know-how.

  • Switching Costs (Operational & Compliance-Driven): Sanitation and water treatment programs are implemented through standardized operating procedures, trained personnel, equipment settings, and documented performance. Changing vendors can require requalification, process resets, and production interruptions—raising effective switching barriers.
  • Technical Intangibles: Formulation expertise, application engineering, and operational troubleshooting build durable customer relationships. Competitors can sell products, but matching outcomes consistently at scale is harder.
  • Scale and Service Footprint: Broad manufacturing capability and field presence support reliable supply and faster issue resolution, which matters in regulated and uptime-sensitive environments.

Competitive benchmarking:

  • Diversey (and broader hygiene/cleaning portfolio providers): competes in cleaning and hygiene solutions, often with a similar equipment/chemical bundling approach. Ecolab’s distinction tends to be deeper application engineering integration and a broader industrial/water treatment platform across end-markets.
  • Veolia (water and wastewater treatment services): competes on large-scale treatment programs and infrastructure-adjacent services. Ecolab typically focuses on chemical solutions and operational performance within customer facilities, where dosing, compliance, and day-to-day execution create more frequent switching friction.
  • Xylem (water technologies): competes in water systems and monitoring technologies. Ecolab’s positioning emphasizes chemistry + application support + integration with customer operating systems, rather than primarily selling hardware-led solutions.

Across these rivals, Ecolab’s industry focus emphasizes embedded, outcomes-based programs for hygiene and water management rather than purely product or infrastructure-led offerings.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, Ecolab’s opportunity is supported by durable end-market needs and structural adoption of outsourcing and compliance-driven performance:

  • Water scarcity and efficiency: Customers seek lower water use, reduced wastewater load, and improved treatment performance—supporting sustained demand for optimized chemistry and treatment programs.
  • Hygiene and infection-control expectations: Higher sanitation standards in healthcare, food production, and hospitality drive recurring chemical and service consumption.
  • Regulatory compliance and documentation: Environmental and public health requirements increase the value of vendors that provide measurement, dosing guidance, and performance verification.
  • Industrial modernization and outsourcing: Many facilities prefer specialized chemical and application support to internalize expertise, creating recurring service-related spend.
  • Sustainability-linked optimization: Customers increasingly target reduction in chemical usage, energy, and waste; optimized programs can support both volume stability and selective pricing/mix improvements.

⚠ Risk Factors to Monitor

  • Input cost and logistics volatility: Specialty chemical supply chains can face cost swings, impacting margins if pass-through timing lags.
  • End-market cyclicality: Industrial activity and hospitality/food throughput can affect chemical volumes.
  • Regulatory and product liability: Increased scrutiny of chemical substances and sanitation practices can raise compliance costs and create litigation exposure.
  • Technology and formulation disruption: Shifts in disinfectant chemistry, filtration approaches, or treatment methodologies could pressure differentiation if competitors offer superior outcomes or cost structures.
  • Concentration and customer contracting dynamics: Large accounts may renegotiate pricing or shift programs, particularly when service differentiation is not perceived as value-accretive.
  • Execution risk in scale and capacity planning: Field service productivity, manufacturing reliability, and integration of portfolio changes are critical to sustaining margin and service quality.

📊 Valuation & Market View

Ecolab is typically valued as a quality industrial/consumer-adjacent services and specialty chemicals business, often anchored to EV/EBITDA and earnings power rather than pure asset value. Key valuation sensitivities include:

  • Quality of earnings: stability of recurring-like consumables and services vs. purely transactional exposure.
  • Margin structure: pricing discipline, service mix, and operational leverage that influence sustainable operating margins.
  • Cash conversion: working-capital management and capex intensity relative to earnings.
  • Growth durability: evidence of penetration and retention tied to operational outcomes, not just volume.

Because the business benefits from embedded customer programs, investors generally pay higher multiples when visibility into service continuity, pricing power, and margin resilience are credible.

🔍 Investment Takeaway

Ecolab’s long-term thesis rests on embedded switching costs created by integrated hygiene and water treatment programs, supported by application engineering capabilities and a broad service footprint. The competitive landscape is active, but replicating consistent outcomes and operational integration at customer sites is difficult—creating durable customer retention and supporting steady earnings power. Monitoring margin durability through input-cost cycles, regulatory exposure, and end-market demand remains central to underwriting the investment.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for ECL.

seekingalpha.com2026-06-02

Ecolab Inc. (ECL) Presents at 46th Annual William Blair Growth Stock Conference Transcript

Ecolab Inc. (ECL) Presents at 46th Annual William Blair Growth Stock Conference Transcript

zacks.com2026-05-28

Ecolab (ECL) Up 2.3% Since Last Earnings Report: Can It Continue?

Ecolab (ECL) reported earnings 30 days ago. What's next for the stock?

businesswire.com2026-05-27

Ecolab Schedules Webcast of Industry Conference for June 2, 2026

ST. PAUL, Minn.--(BUSINESS WIRE)--Scott Kirkland, CFO, will address financial analysts at the William Blair Annual Growth Stock Conference on Tuesday June 2, 2026. Ecolab will offer a webcast of Mr. Kirkland's presentation. Details for the webcast are as follows: TIME: 10:00am CT DATE: June 2, 2026 DURATION: Approximately 30 minutes LOCATION: www.ecolab.com/investor ARCHIVE: A replay of the webcast will be available through September 2, 2026. To access the webcast, visit the Events & Presen.

zacks.com2026-05-21

Here's Why You Should Retain Ecolab Stock in Your Portfolio Now

ECL's strong Q1 earnings, digital growth and expanding high-tech platform support long-term upside despite rising cost pressures.

zacks.com2026-05-19

Insiders Are Buying These 3 Stocks

Many investors keep a close eye on insider transactions, as they can often give a decent read surrounding the longer-term picture.

businesswire.com2026-05-12

Ecolab Delivers Strong Performance and Impact

ST. PAUL, Minn.--(BUSINESS WIRE)--The world is entering a period of historic growth, complexity and opportunity. As artificial intelligence reshapes industries and demand for energy, food and water accelerates, how companies grow next will matter as much as how fast they grow. In a rapidly changing world, Ecolab remains constant. Today, the company released its 2025 Growth & Impact Report highlighting how Ecolab continues to deliver strong business performance while deepening its impact on.

marketbeat.com2026-05-11

Ecolab Holders Reject Independent Chair Proposal as Beck Touts Record Year, AI Growth

Ecolab NYSE: ECL shareholders re-elected the company's 13 director nominees and rejected a stockholder proposal calling for an independent board chair policy at the company's annual meeting, where Chairman, President and Chief Executive Officer Christophe Beck also outlined the company's 2025 performance and growth priorities.

businesswire.com2026-05-07

Ecolab Declares Cash Dividend

ST. PAUL, Minn.--(BUSINESS WIRE)--The board of directors of Ecolab Inc. today declared a regular quarterly cash dividend of $0.73 per common share, to be paid July 15, 2026, to shareholders of record at the close of business on June 16, 2026. Ecolab has paid cash dividends on its common stock for 89 consecutive years. About Ecolab A trusted partner for millions of customers, Ecolab (NYSE:ECL) is a global leader in water, hygiene and infection prevention solutions and services that protect peopl.

businesswire.com2026-04-29

Ecolab to Webcast Annual Meeting on May 7, 2026

ST. PAUL, Minn.--(BUSINESS WIRE)--Ecolab will host a live webcast of its annual meeting of stockholders. As indicated in our proxy statement, the 2026 Annual Meeting of Stockholders will be a virtual-only meeting. Details for the public webcast are as follows: TIME: 9:30 a.m. Central Time     DATE: Thursday, May 7, 2026     DURATION: Approximately 30 minutes     LOCATION: www.virtualshareholdermeeting.com/ECL2026     ARCHIVE: A replay of the webcast will be available 24 hours after the end of t.

defenseworld.net2026-04-29

Comerica Bank Trims Stock Position in Ecolab Inc. $ECL

Comerica Bank reduced its stake in shares of Ecolab Inc. (NYSE: ECL) by 6.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 63,721 shares of the basic materials company's stock after selling 4,440 shares during the quarter. Comerica

defenseworld.net2026-04-29

Concurrent Investment Advisors LLC Buys 2,533 Shares of Ecolab Inc. $ECL

Concurrent Investment Advisors LLC lifted its stake in Ecolab Inc. (NYSE: ECL) by 38.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,159 shares of the basic materials company's stock after acquiring an additional 2,533 shares during the period.

zacks.com2026-04-29

Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Basic Materials Names

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

businesswire.com2026-04-29

Ecolab Life Sciences Expands Global Bioprocessing Capabilities With New Advanced Development and Applications Center in Korea

SEOUL, South Korea--(BUSINESS WIRE)--Building on the continued growth and strong performance of its Life Sciences business, Ecolab is further expanding its global bioprocessing capabilities to support biopharmaceutical manufacturers worldwide. Today, Ecolab Life Sciences announced the opening of a new Bioprocessing Applications Lab (BPAL) in Dongtan, Korea, its first bioprocessing facility in Asia. The new center further strengthens the company's global Life Sciences footprint and supports cust.

gurufocus.com2026-04-29

Ecolab Inc (ECL) Q1 2026 Earnings Call Highlights: Strong Growth Amidst Challenges

Adjusted Diluted EPS Growth: 13% growth in the first quarter.Organic Sales Growth: 4% increase, driven by 3% value pricing and 1% volume growth.Operating Incom

seekingalpha.com2026-04-28

Ecolab Inc. (ECL) Q1 2026 Earnings Call Transcript

Ecolab Inc. (ECL) Q1 2026 Earnings Call Transcript

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"ECL reported Q1 2026 revenue of $4.07B, up 7.0% YoY (vs $3.70B in Q1 2025) and down 3.0% QoQ (vs $4.20B in Q4 2025). Net income was $432.6M, up 6.3% YoY (vs $402.5M in Q1 2025) but down 23.3% QoQ (vs $563.9M in Q4 2025). EPS was $1.53 vs $1.42 YoY (+7.7%) and below $2.00 QoQ (-23.5%). Profitability appears mixed: the net margin fell to 10.64% from 13.44% in Q4 2025, indicating margin compression QoQ, while remaining slightly below Q1 2025’s 10.89% (minor YoY softness). Operating income declined QoQ as well ($622.0M vs $785.9M). Cash flow quality is a relative bright spot: operating cash flow was $445.9M and free cash flow was $97.4M. This is down sharply QoQ in absolute terms versus Q4’s $758M free cash flow, but still supports dividends of $215.9M. Leverage remains meaningful with total debt of $9.10B and net debt of $8.58B, while equity was $10.03B. Total shareholder return is supported by a 1-year price change of +16.46% (not >20% momentum). With a very low dividend yield (~0.29%), most shareholder return is likely price-driven rather than income-driven. Analyst valuation context shows a consensus price target of 327.11 vs current price 274.8 (upside ~19%)."

Revenue Growth

Positive

Q1 2026 revenue grew +7.0% YoY but declined -3.0% QoQ, suggesting solid annual demand but softer sequential momentum.

Profitability

Neutral

Net margin contracted QoQ (10.64% vs 13.44%) while remaining roughly flat YoY (10.64% vs 10.89%). EPS rose +7.7% YoY but fell -23.5% QoQ.

Cash Flow Quality

Fair

Operating cash flow was $445.9M and free cash flow was $97.4M; both were materially lower QoQ. Dividends were paid ($215.9M), but FCF coverage weakened versus the prior quarter.

Leverage & Balance Sheet

Neutral

Total assets were $25.04B with equity of $10.03B. Leverage remains elevated (net debt ~$8.58B), though equity is broadly stable vs prior quarters.

Shareholder Returns

Neutral

1y price change is +16.46% (positive but below the >20% momentum threshold). Dividend yield is low (~0.29%), so total returns are likely mostly capital appreciation.

Analyst Sentiment & Valuation

Good

Consensus target is 327.11 vs price 274.8, implying ~19% upside. High-price multiples exist, but analyst outlook appears supportive.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Ecolab delivered a strong Q1 2026: adjusted diluted EPS +13% and organic sales +4% (3% value pricing; volume acceleration to 1%). Margin performance improved, with organic operating income margin up 70 bps to 16.8% driven by SG&A productivity from scaling digital/AI-native capabilities; gross margin stayed steady underlying despite commodity inflation, though reported gross margin was temporarily pressured by M&A and higher commodities. The key near-term risk is energy/commodity inflation from the Middle East and broader supply chain effects. Management implemented an April 1 energy surcharge and guided that Q2 will be a transition quarter with high-single-digit commodity cost increases and a “few percentage points” EPS drag, but expects gross margin stabilization in 2H and EPS strengthening in Q3/Q4. Underlying EPS growth remains within the 12%–15% range for 2026, excluding CoolIT’s short-term $0.20/quarter dilution (neutral in 2027). Strategically, High Tech + Life Sciences + Pest/Digital are gaining momentum, supporting the 20% operating margin target by 2027 and re-accelerating growth/mix toward less energy exposure.

AI IconGrowth Catalysts

  • Global High Tech and Digital growth >20%, driven by digital adoption and the AI wave (circular water management and high-performance cooling demand)
  • Life Sciences organic growth accelerated to 11%, led by bioprocessing with sales more than doubling
  • Pest Elimination grew 7%, supported by One Ecolab share gains and the new Pest Intelligence offering
  • Specialty grew 9% driven by innovation helping customers optimize costs
  • Food & Beverage outgrew end markets at 5%, supported by One Ecolab execution

Business Development

  • Pending CoolIT acquisition: CoolIT reported Q1 2026 sales growing well ahead of the 30%+ discussed on the acquisition call
  • OVIVO acquisition referenced as contributing to second-half gross margin dynamics and cross-sell narrative
  • Referenced Global High Tech platform combining legacy cooling/water business with OVIVO and (post-close) CoolIT into a $1.5B growth powerhouse

AI IconFinancial Highlights

  • Adjusted diluted EPS grew 13% (mid-point of management’s range); organic sales grew 4% with value pricing of 3% and volume growth accelerating to 1%
  • Organic operating income margins expanded 70 bps to 16.8% (underlying SG&A productivity improved materially via scaling digital/AI-native capabilities)
  • Reported gross margin slightly lower due to short-term impact from recent M&A and higher commodity cost inflation; underlying gross margin steady as value pricing offset commodity inflation
  • Energy-driven supply chain pressure prompted an energy surcharge; commodity costs expected to increase high single digits beginning Q2 and remain high through year-end (pressure on Q2 EPS growth by a few percentage points)
  • Second-half gross margin expected to stabilize; ex-OVIVO gross margins would be up 70–80 bps in the second half
  • Full-year adjusted diluted EPS growth expected 12%–15% in 2026 excluding short-term impact from pending CoolIT acquisition; CoolIT financing + non-cash amortization expected to reduce EPS by about $0.20 per quarter in the second half (neutralizes in 2027 via Nalco amortization roll-off)
  • Second-half operating environment assumption: 9% commodity inflation, pricing 5%–6%, and ~1% volume growth leading to 6%–7% top-line growth for the second half

AI IconCapital Funding

  • No explicit buyback/debt/cash runway amounts provided in the transcript

AI IconStrategy & Ops

  • Implemented energy surcharge quickly (starting April 1) to absorb energy/commodity increases and preserve margin stabilization trajectory
  • Scaling “One Ecolab” (service + expertise + breakthrough technology) to drive mix shift toward higher-margin/higher-growth end markets
  • Investment and capacity build in Life Sciences (notably bioprocessing) including a plant opening expected in the second half of the year
  • Cross-product integration plan post-CoolIT/OVIVO within Global High Tech for integrated, service-led cooling solutions for high-density AI data centers

AI IconMarket Outlook

  • 2026 adjusted diluted EPS growth: 12%–15% (unchanged) excluding short-term CoolIT impact
  • Q2 described as a short transition quarter; commodity costs expected high single digits starting in Q2 and high through year-end; surcharge benefits building through the quarter following April 1 implementation
  • Second half: operating income/gross margin stabilize; ex-OVIVO gross margin +70–80 bps; EPS growth expected to strengthen in Q3 and Q4
  • Longer-term: operating income margin target 20% by 2027; objective for 2027 EPS growth to remain 12%–15% with CoolIT included and Nalco amortization roll-off offsets CoolIT incremental amortization
  • Life Sciences near-term: double-digit growth expected to persist; operating income margin to expand toward ~30% over the next few years (intermediate expectation mid-20s while investing)

AI IconRisks & Headwinds

  • Commodity/energy inflation: commodity costs expected to rise high single digits starting in Q2 and stay high through year-end; Q2 EPS growth pressured by “a few percentage points” despite surcharge
  • Middle East conflict: sharply higher global energy costs creating additional supply chain pressure
  • Paper and Heavy Water: stabilized after prior underperformance; remaining risk is whether they turn slightly positive in 2H (management says bottom reached and expects improvement)

Q&A: Analyst Interest

  • Pricing vs margin math: Management tied faster gross margin stabilization in 2H to earlier energy/commodity surcharge timing (implemented April 1) and value-pricing recovery. They quantified DPC energy exposure (~30% energy-impacted) versus compensation needed (~2.5%) and said 5%–6% pricing should stabilize margins despite high-single-digit commodity inflation through year-end.
  • Macro sensitivity and demand assumptions: Management emphasized guidance is ~90% execution-led with conservative assumptions—9% commodity inflation through year-end (and likely into next year) and ~1% volume growth in 2H. They acknowledged demand may have plus/minus globally but argued core performance and growth engines mitigate macro swings versus customer “cautious posture” risks.
  • CoolIT and accretion/dilution mechanics: Management clarified CoolIT’s EPS dilution is about $0.20 per quarter in the second half (close timing drives per-quarter impact). They stated it neutralizes in 2027 because incremental non-cash amortization from CoolIT is offset by Nalco non-cash amortization roll-off; therefore EPS growth should remain 12%–15% in 2027.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the ECL Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for ECL.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (ECL)

© 2026 Stock Market Info — Ecolab Inc. (ECL) Financial Profile